1. Home
  2. FBIN vs ACLX Comparison

FBIN vs ACLX Comparison

Compare FBIN & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

HOLD

Current Price

$42.11

Market Cap

6.2B

ML Signal

HOLD

Logo Arcellx Inc.

ACLX

Arcellx Inc.

HOLD

Current Price

$115.02

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIN
ACLX
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.7B
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
FBIN
ACLX
Price
$42.11
$115.02
Analyst Decision
Hold
Hold
Analyst Count
11
15
Target Price
$54.60
$115.85
AVG Volume (30 Days)
2.9M
860.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.51%
N/A
EPS Growth
N/A
N/A
EPS
2.47
N/A
Revenue
$4,463,200,000.00
$22,286,000.00
Revenue This Year
$2.68
$342.39
Revenue Next Year
$3.60
$170.71
P/E Ratio
$16.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$47.86
52 Week High
$64.84
$115.13

Technical Indicators

Market Signals
Indicator
FBIN
ACLX
Relative Strength Index (RSI) 52.36 80.04
Support Level $36.07 $66.06
Resistance Level $53.19 N/A
Average True Range (ATR) 1.65 0.12
MACD 0.79 -0.80
Stochastic Oscillator 94.67 77.66

Price Performance

Historical Comparison
FBIN
ACLX

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Share on Social Networks: